Search results for "Lung cancer"

ApparatusAug 09, 2025

J. Enzyme Inhib. Med. Chem. | Protac Targeting Aimp2-Dx2: a New Therapy For Lung Cancer
MedicalAug 08, 2025

Frequent CT After Lung Cancer Surgery For Fear Of Recurrence?
MedicalJul 02, 2025

More Significant Survival Benefit For Non-Small Cell Lung Cancer Patients Under 55 Years Of Age, Also Using Immunotherapy!
ApparatusJun 30, 2025

Over 30% Of Tumours In Advanced Lung Cancer Patients In Remission With Frontier Drug Teliso-V In Combination With Troche!
MedicalJun 11, 2025

K-Drug Approved For Adjuvant Treatment Of Early-Stage Non-Small Cell Lung Cancer, Significantly Extending Cancer-Free Survival Of Patients!
ApparatusMay 22, 2025

Good Clinical Data For SRF388, An Innovative Lung Cancer Drug, With Patients Stable For
MedicalMar 22, 2025

Study Shows Drug Halves Recurrence Rate In Patients With Early-Stage EGFR-Mutated Lung Cancer!
MedicalFeb 21, 2025

New Treatment For Lung Cancer Approved! Significantly Better Than Chemotherapy!
DiseaseAug 07, 2023

J Thorac Oncol: Survival Differences In Lung Cancer Patients By Gender And The Impact Of Prognostic Factors On Them

ApparatusAug 11, 2025

Nature Medicine publishes results of H-drug combined with chemotherapy for first-line treatment of esophageal squamous cell carcinoma

HospitalMay 23, 2025

Sheba Medical Center at Tel HaShomer - Top 10 Best Hospitals in the World

HealthyJun 29, 2025

How can patients with poor heart survive the summer?

ApparatusJul 04, 2025

Immune And Astrazeneca Launch Strategic Research Collaboration To Accelerate Drug Target Discovery

HospitalApr 22, 2025

UCLA Health University of California, Los Angeles Medical Center.

DiseaseJul 24, 2025

How Confirm The Diagnosis Of Highly Differentiated Cholangiocarcinoma With Lymph Node Metastasis? How To Treat Highly Differentiated Cholangiocarcinoma With Metastatic Lymph Nodes?

Search results for "Lung cancer"

World's 2nd KRAS Inhibitor Approved For Non-Small Cell Lung Cancer With 80% Efficacy!

Apparatus

J. Enzyme Inhib. Med. Chem. | Protac Targeting Aimp2-Dx2: a New Therapy For Lung Cancer

Frequent CT After Lung Cancer Surgery For Fear Of Recurrence?

More Significant Survival Benefit For Non-Small Cell Lung Cancer Patients Under 55 Years Of Age, Also Using Immunotherapy!

Over 30% Of Tumours In Advanced Lung Cancer Patients In Remission With Frontier Drug Teliso-V In Combination With Troche!

K-Drug Approved For Adjuvant Treatment Of Early-Stage Non-Small Cell Lung Cancer, Significantly Extending Cancer-Free Survival Of Patients!

Good Clinical Data For SRF388, An Innovative Lung Cancer Drug, With Patients Stable For

Study Shows Drug Halves Recurrence Rate In Patients With Early-Stage EGFR-Mutated Lung Cancer!

New Treatment For Lung Cancer Approved! Significantly Better Than Chemotherapy!

J Thorac Oncol: Survival Differences In Lung Cancer Patients By Gender And The Impact Of Prognostic Factors On Them

YOU MAY LIKE